PROCESS FOR MANUFACTURING SUSTAINED RELEASED MICROBEADS CONTAINING VENLAFAXINE HCI THAT THE PROVISIONAL SPECIFICATION RELATING TO THIS INVENTION IS FILED WITH THIS APPLICATION

摘要

The present invention relates to viable continuous process for manufacture of agglomeration free, high yield (generally atleast about 95% w/w), uniformly shaped and sized, stable novel pharmaceutical composition of adequate strength comprising upto about 70%w/w of Venlafaxine or its pharmaceutical acceptable salt which is free of organic acid for once a day dosing. Sustained release composition comprising of Venlafaxine HCI provides pH independent release of Venlafaxine HCI atleast for a period of 10 hours without any latent period and can be encapsulated in smallest capsule size 5 for therapeutic effective of Venlafaxine thus providing patient easy to consume dosage form. To